NVO · Novo Nordisk
AI read · Good for NVO
The AI's read
This gives Novo Nordisk another group of children it can treat with Sogroya. The trial showed the treatment worked and was safe for these children. The report gives no sales estimate, so the size of the benefit is unknown.